Discover

KMTS
Kestra Medical Technologies, Ltd.
26.28
2 x 19.70
2 x 33.28
bid
ask
+
0.84
3.30%
2 @ 04:00 PM
26.28 +0.00 (0.00%)
Ytd-0.90%
1y65.91%
25.78
day range
27.84
13.25
52 week range
30.00
Open25.78Prev Close25.44Low25.78High27.84Mkt Cap1.53B
Vol752.41KAvg Vol314.38KEPS-5.46P/EN/AForward P/E-11.89
BetaN/AShort Ratio9.88Inst. Own102.87%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-1450-d Avg21.27200-d Avg23.511yr Est27.71
Earning
DateForEstimateReportedSurprisesurprise %
2026-03-172026-010N/AN/AN/A
2025-12-112025-100N/AN/AN/A
2025-12-112025-100N/A-0.06-10.71%
2025-09-112025-070N/AN/AN/A
2025-09-112025-070N/A0.230.30%
2025-07-152025-040N/AN/AN/A
Upgrade / Downgrade
DateFirmActionFromTo
2026-04-09Goldman SachsUpgradeNeutralNeutral
2026-04-07BTIGUpgradeBuyBuy
2026-03-25BTIGUpgradeBuyBuy
2026-03-18BTIGUpgradeBuyBuy
2025-12-15Goldman SachsUpgradeNeutralNeutral
2025-12-12Wells FargoUpgradeOverweightOverweight
Profile
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.
Insider Holder
DateNameRelationQuantityDescription
2026-03-25COHEN RAYMOND WDirector50.90KPurchase
2026-06-02FORD ALFRED J. JROfficer74.64KStock Award(Grant)
2025-09-03HANLEY CONORDirector13.12KStock Award(Grant)
2025-09-03KWO ELIZABETHDirector10.91KStock Award(Grant)
2025-09-03LADONE MARY KAYDirector23.90KStock Award(Grant)
2026-06-02MAHBOOB VASEEMChief Financial Officer67.96KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30Bain Capital Investors Llc25.17M661.53M43.12%
2026-03-30Price (T.Rowe) Associates Inc5.97M156.86M10.22%
2026-03-30FMR, LLC5.72M150.35M9.80%
2026-03-30Andera Partners2.70M70.83M4.62%
2026-03-30Yu Fan2.28M59.98M3.91%
2026-03-30Brown Advisory Inc.1.72M45.30M2.95%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30T. Rowe Price New Horizons Fund, Inc.2.59M68.11M4.44%
2026-03-30MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund1.37M35.95M2.34%
2026-03-30-Price (T.Rowe) New Horizons Trust1.25M32.88M2.14%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund967.71K25.43M1.66%
2026-05-30Fidelity Select PORT.s-Select Medical Technology and Devices PORT.950.00K24.97M1.63%
2026-05-30Fidelity Select Portfolios-Select Health Care Portfolio900.00K23.65M1.54%